Back
Valion Bio, Inc. VBIO · Insights
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Ento... Price0.5007
Market Cap1.16 M
Float2.15 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro